MedPath

The CAVIAR-trial

Not yet recruiting
Conditions
Persistent and longstanding persistent atrial fibrillation
Registration Number
NL-OMON20520
Lead Sponsor
niversity Medical Center Utrecht (UMCU)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

Patients age is > 18 years

- Patients with persistent or longstanding persistent atrial fibrillation. Persistent AF is defined as sustained episodes of atrial fibrillation lasting >7 days. Longstanding persistent AF is defined as sustained episode lasting >1 year.

Exclusion Criteria

- Patients suffering from paroxysmal atrial fibrillation. Paroxysmal AF is defined as episodes of AF that terminates spontaneously within 7 days.

- Patients suffering from AF secondary to a reversible cause as electrolyte imbalance or hyperthyroidism.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary objective of the study is to evaluate which treatment- surgical ablation or catheter ablation- is most effective in treating persistent and longstanding persistent atrial fibrillation measured by success at 12 months after 1 procedures.
Secondary Outcome Measures
NameTimeMethod
The incidence of periprocedural complications, clinical success after 12 months, procedural duration, number of repeat procedures, success and clinical success after 2 procedure after 12 months, quality of life measurements before and 6 months after the first procedure.
© Copyright 2025. All Rights Reserved by MedPath